GT
LTHM

Glenmede Trust’s Livent Corporation LTHM Stock Holding History

Glenmede Trust’s Portfolio LTHM Stock Details LTHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18,032
Closed -$332K – 1349
2023
Q3 		$332K Sell
18,032
-8,363
-32% -$191K ﹤0.01% 961
2023
Q2 		$573K Hold
26,395
– – ﹤0.01% 798
2023
Q1 		$573K Sell
26,395
-5,145
-16% -$119K ﹤0.01% 801
2022
Q4 		$627K Buy
31,540
+6,975
+28% +$191K ﹤0.01% 775
2022
Q3 		$752K Buy
24,565
+5,755
+31% +$161K ﹤0.01% 722
2022
Q2 		$426K Buy
+18,810
New +$484K ﹤0.01% 904
2020
Q4 		– Sell
-4,305
Closed -$38K – 2376
2020
Q3 		$38K Sell
4,305
-371
-8% -$2.79K ﹤0.01% 1410
2020
Q2 		$28K Buy
4,676
+371
+9% +$2.34K ﹤0.01% 1479
2020
Q1 		$36K Hold
4,305
– – ﹤0.01% 1822
2019
Q4 		$36K Buy
4,305
+762
+22% +$5.83K ﹤0.01% 1822
2019
Q3 		$23 Buy
3,543
+36
+1% +$242 ﹤0.01% 1988
2019
Q2 		$24 Buy
3,507
+188
+6% +$1.69K ﹤0.01% 2001
2019
Q1 		$40 Buy
+3,319
New +$43.3K ﹤0.01% 1784

Other funds holding LTHM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Glenmede Trust's LTHM Position: Q4 2023 in Review

Glenmede Trust sold out of Livent Corporation (LTHM) in Q4 2023, closing a stake of 18,032 shares — an estimated $332K sold.

Glenmede Trust first reported a position in LTHM in Q1 2019 and held it in 13 quarters. The position peaked at $752K in Q3 2022. 382 funds tracked by Wall St. Rank hold LTHM as of Q4 2023.

  • Glenmede Trust reported no remaining Livent Corporation position as of Q4 2023 after selling out during the quarter.
  • Glenmede Trust sold 18,032 Livent Corporation shares in Q4 2023, an estimated $332K.
  • Glenmede Trust first reported a position in Livent Corporation in Q1 2019 and held it in 13 quarters.
  • Glenmede Trust's Livent Corporation position peaked at $752K in Q3 2022.
  • 382 funds tracked by Wall St. Rank held Livent Corporation as of Q4 2023.

Based on Glenmede Trust's 13F filing for Q4 2023, filed 13 Feb 2024.